Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 281-300 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 281 | Beyond Gravity lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence survived the 90-day recent evidence window. Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent. Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent. |
| 282 | Blackstar Orbital lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers only relation-style context and no direct positive evidence, so there is no supportable opportunity thesis. Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided. Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources. |
| 283 | Canada Rocket Company lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates membership support that Canada Rocket Company was identified as one of three Canadian rocket startups receiving government funding, but no within the recent evidence window direct positive evidence or article summaries are available for scoring, so opportunity evidence is too thin to form a positive thesis from these reviewed sources alone. Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen. Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence. |
| 284 | Canon Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources contain no direct positive evidence for Canon within the scoring window. The membership rationale says Canon is mentioned only as one of Rocket Lab's partners/customers in a CubeSat article, which is too incidental to support a company-level opportunity thesis. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context. |
| 285 | Capella Space lowweak | Opp 1 Risk 1 | Thesis: This reviewed sources slice references only competitive landscape and generic market-report mentions in the phase-2 rationale, with no retained direct positive evidence in the recent evidence window, so there is not enough support for a positive thesis. Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent. Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used. |
| 286 | Casimir Inc. lowweak | Opp 1 Risk 2 | Thesis: The only possible positive read is from the phase2 rationale, which says Casimir raised a $12M seed round and is tied to a NASA-veteran founder. If accurate, recent financing could support development over a 1 year+ horizon, but the reviewed sources does not include a citable article /summary and also notes the business described is quantum vacuum energy chips rather than a clearly defined target space operating category. Why now: There is no available article summary or evidence row after recent evidence window, so the only 'why now' is the uncitable phase2 statement about a seed round referenced by article id: without. Caveats: The reviewed sources itself says the support article is blog commentary, weakening source quality. No citable or summary is provided for the referenced article id No evidence were available after recent evidence window in the served reviewed sources. |
| 287 | China Aerospace Science and Technology Corporation lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not load any direct positive evidence within the 90-day recent evidence window, so no positive thesis is supported. Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources. Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 288 | China Rocket lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient direct positive evidence for a durable opportunity thesis. Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window. Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available. |
| 289 | China Spacesat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says an opinion piece listed China Spacesat among global space companies, with no direct facts or events specific to the company retained after recent evidence window, so there is no evidence basis for a positive thesis. Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window. Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence. |
| 290 | Chunghwa Telecom Co., Ltd. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from the retained reviewed sources evidence because there is no direct positive evidence after recent evidence window. Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided. Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company. |
| 291 | Clear Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only indicates that Clear Space develops space lidars in a space or aerospace context. That is not enough to support a meaningful positive thesis over a 1 year+ horizon without current financing, contracts, or milestone evidence. Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources. Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed. |
| 292 | Collins lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources notes many mentions tied mainly to RTX/Raytheon and market lists, but does not cleanly establish 'Collins' as a target company with direct positive business evidence in the recent evidence window. Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or. Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered. |
| 293 | Comtech Telecommunications Corp. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence or representative article summaries are provided within the recent evidence window. Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources. Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields. |
| 294 | Cosmoserve lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources rationale weakly suggests possible opportunity because Cosmoserve is mentioned among Indian space-tech startups and the article notes product-technologies including satellite communications. But the reviewed sources does not directly describe Cosmoserve's own business or provide a citable article summary/ in the recent evidence window. Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing. Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window. |
| 295 | Cosmoserve Space lowweak | Opp 1 Risk 1 | Thesis: The company is described in membership rationale as participating in debris removal and RPOD-related activity, but no retained 90-day direct positive evidence supports a forward opportunity thesis. Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update. Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears. |
| 296 | Digantara lowweak | Opp 1 Risk 1 | Thesis: The membership rationale suggests funding and space situational awareness relevance, but the served reviewed sources retains no 90-day positive evidence to support a long-horizon opportunity thesis. Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data. Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment. |
| 297 | Digantara lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates Digantara is relevant to space situational awareness and references a missile tracking satellite, which could imply strategic relevance, but there is no usable in-window article or evidence available for directional scoring. Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing. Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources. |
| 298 | DPhi Space lowweak | Opp 1 Risk 1 | Thesis: Only a minimal opportunity view is possible because the phase2 rationale says DPhi Space was using Solstar's Deke system and was identified as Swiss, implying some active space-company involvement. But the reviewed sources explicitly says the business fit remains indirect and thin. Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst. Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window. |
| 299 | EarthDaily lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources membership rationale says EarthDaily received an NRO contract for EO/IR under Strategic Commercial Enhancements, which could support a long-horizon government-demand opportunity, but no within the recent evidence window evidence or article details were available to substantiate the claim for ranking use in this screen. Why now: Why now is weak because the reviewed sources show zero evidence kept within the 90-day recent evidence window for ranking, making recency and business-state assessment uncertain. Caveats: Phase-2 membership rationale references: but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Cannot treat cohort membership as thesis attractiveness. |
| 300 | Elbit Systems Ltd. lowweak | Opp 1 Risk 1 | Thesis: Despite broad defense and space-adjacent relevance in the membership rationale, the reviewed sources have no direct positive evidence within the recent evidence window, so no positive 1 year+ thesis is supportable. Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources. Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources. |
Risk view
Showing rows 1-20 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 1 | Blue Origin mediummedium | Opp 6 Risk 7 | Thesis: Execution risk is elevated because the same recent evidence set documents a New Glenn launchpad explosion on May 28, 2026, creating material uncertainty around launch reliability and schedule even though government customers reaffirmed support. Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026 Evidence
Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk. |
| 2 | Katalyst Space Technologies highstrong | Opp 8 Risk 6 | Thesis: Risk is also elevated because the mission profile is technically ambitious and schedule-sensitive: the rescue concept is framed as potentially the first time a commercial robotic spacecraft docks with an unprepared government satellite, and the telescope is described as at risk of deorbit by late 2026, implying high execution stakes. Why now: Why now is strong because the latest dated evidence on June 23, 2026 adds new capital after the May 29, 2026 NASA-related mission context, supporting a 1 year+ thesis that the company is moving from concept credibility toward funded development in on-orbit servicing. Evidence
Caveats: Part of the positive case comes from company-issued materials and supporting article context rather than independent positive evidence. The May 29, 2026 article includes a dated source date but describes an announcement text beginning 'August 11, 2025'; chronology should therefore be read carefully, with the treated as the recency marker for this retrieved item. Citation |
| 3 | Anduril Industries mediummedium | Opp 7 Risk 5 | Thesis: Risk remains elevated because the reviewed sources' evidence is mostly supporting article context rather than company-specific positive evidence, and program participation does not confirm revenue realization, production conversion, or margin outcomes. The capital raise also implies a company still in heavy scale-up mode rather than de-risked execution. Why now: The timing is supported by recent 2026 article context around Space Force Andromeda participation and the June 19, 2026 financing context, which together suggest active momentum over the last quarter. Evidence
Caveats: Most evidence is weak context-only article evidence, not direct positive events in the available ranking rows. |
| 4 | AST SpaceMobile, Inc. highstrong | Opp 8 Risk 5 | Thesis: Risk remains elevated because the thesis still depends on large-scale deployment and commercialization execution; the reviewed sources show authorization and partnerships, but limited direct proof of broad revenue conversion or completed network rollout inside the recent evidence window. Why now: The key timing event is the FCC authorization dated April 21, 2026/April 22, 2026 granting authority for up to 248 satellites and direct-to-device service, a milestone that can unlock U.S. commercial and government use cases over a 1 year+ horizon. Later-dated company-site context on June 23, 2026 also says AST has nearly 60 operator partners and targets direct broadband to standard smartphones. Evidence
Caveats: Much of the evidence is company, press-release, or article-context based rather than independent hard performance metrics. The reviewed sources cites a target of 45 to 60 BlueBird satellites by end-2026 in article summary context, but this is not available as a direct structured fact here. |
| 5 | Atomic-6 lowweak | Opp 4 Risk 5 | Thesis: Risk is moderate because none of the underlying article summaries or are provided in the visible evidence section, so the apparent positives cannot be independently grounded from the reviewed sources output beyond the rationale text. Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited. Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low. |
| 6 | Intuitive Machines, Inc. mediummedium | Opp 6 Risk 5 | Thesis: Risk is also moderate because the evidence is lighter than for top-ranked names and the key contract appears to be an IDIQ selection/competition vehicle rather than a clearly quantified standalone revenue award in the reviewed sources. Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition. Evidence
Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs. |
| 7 | Momentus mediummedium | Opp 7 Risk 5 | Thesis: Risk remains elevated because the evidence set emphasizes announcements and pipeline/contract positioning rather than broad proof of scaled recurring commercial adoption; some supportive contract context, including SHIELD selection, is older than the recent evidence window and should not be over-weighted for recency. Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio. Evidence
Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation. |
| 8 | Momentus Inc lowweak | Opp 4 Risk 5 | Thesis: Momentus receives the highest risk score in the thin-evidence group because the reviewed sources references a commercial contract but provides no current available corroboration, leaving substantial uncertainty around execution, financing durability, and contract conversion. This is still an evidence-gap risk, not a confirmed adverse-event thesis, because no direct negative evidence is available (: and: unavailable in reviewed sources). Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence. Caveats: No direct evidence remained after the recent evidence filter. |
| 9 | Orbex mediumweak | Opp 1 Risk 5 | Thesis: Risk is moderate because the only described usable context says the company was looking to secure its future, while all dated evidence shown is outside the allowed recent evidence window, leaving the current business state uncertain. Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent. Evidence
Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available. |
| 10 | Orbital Inc. mediummedium | Opp 6 Risk 5 | Thesis: Risk is moderate because the reviewed sources provide only supporting article context and no direct evidence of contracts, deployment milestones, customer traction, or technical validation beyond the funding/context claim. Why now: The usable evidence is recent within the 90-day recent evidence window: an April 14, 2026 article said Orbital got funded by Andreessen Horowitz to verify its space-based data center concept, which is relevant to a 1 year+ horizon because financing can support technology proof and strategic positioning Evidence
Caveats: Evidence is supporting article context/weak context rather than direct positive events. No reviewed sources evidence of customers, revenue, launch schedule, or technical milestone completion. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 11 | Quantum Space mediummedium | Opp 8 Risk 5 | Thesis: The company still carries meaningful execution and transaction risk because the SPAC deal is only expected to close in the fourth quarter rather than already complete, contract value was undisclosed, and key program delivery is pushed out to 2028, leaving room for financing, closing, and execution slippage. Why now: The evidence is recent and sequenced: on June 8, 2026 Quantum Space announced its planned SPAC merger and expected Nasdaq listing under QSPC Evidence
Caveats: Most available evidence is external overlay context rather than first-party positive or negative events. Same-theme repetition across June articles is not independent confirmation. Ticker QSPC is prospective after the expected SPAC close per June 8, 2026 evidence, not confirmed as already trading under that symbol |
| 12 | Sateliot mediummedium | Opp 7 Risk 5 | Thesis: Risk remains material because later evidence indicates the Series C is being sought rather than fully closed and that Sateliot is still seeking a lead investor, with up to 50% public co-financing hoped to match private investment. That means financing completion and constellation deployment remain execution-sensitive. Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon. Evidence
Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments. |
| 13 | Spark Space mediummedium | Opp 5 Risk 5 | Thesis: Risk is equally meaningful because the evidence is undated supporting article context, so recency is uncertain and there is no direct evidence of launch contracts, orbital milestones, or sustained financing beyond the article summary. Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously. Evidence
Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation. |
| 14 | Turion Space mediummedium | Opp 7 Risk 5 | Thesis: Risk remains meaningful because the evidence still describes an early-stage company scaling from a small launched base into a persistent constellation and potentially adjacent on-orbit services, which implies execution and capital deployment risk; however, the reviewed sources contain no direct adverse event evidence. Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon. Evidence
Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation |
| 15 | Volta Space Technologies lowweak | Opp 4 Risk 5 | Thesis: Risk is moderate to elevated because the cited milestone is far out, execution risk is likely high, and the reviewed sources exposes no direct article summary or to confirm near-term de-risking. Why now: The rationale cites article and says the company has a 2028 demonstration planned with payload booked on Blue Ghost Mission 2, which is relevant to a 1 year+ strategic horizon but weak for immediate evidence-based ranking because no article body or is visible. Caveats: No visible representative article, quote, or in the reviewed sources body. The main cited demonstration is scheduled for 2028, so commercial payoff may sit beyond the stated 1 year+ ranking horizon. The Firefly payload linkage cannot be used as counterparty propagation evidence beyond the explicit rationale. |
| 16 | Albedo lowweak | Opp 4 Risk 4 | Thesis: Risk is also meaningful because this evidence is supporting article context only, not direct event/fact evidence in the reviewed sources' stronger fields, and the article describes Albedo as a former Earth-observation startup now focused on satellite manufacturing, implying strategic transition/execution uncertainty Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission Evidence
Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 17 | Apex Space mediummedium | Opp 8 Risk 4 | Thesis: Risk is moderate, not because of explicit adverse evidence, but because the strongest structured support is neutral fact/context rather than explicit positive events in the reviewed sources. The evidence leans heavily on company/external article context and financing narratives, so execution risk around scaling manufacturing and converting strategic positioning into durable contracts remains an offset. Why now: Why now is strong because the key financing evidence is dated June 5, 2026 and the Northrop partnership article is dated June 1, 2026, making both recent within the 90-day recent evidence window and relevant to a 1 year+ scaling thesis. The June 5 financing event is later than the April 16 capacity/context article and therefore better reflects current business state. Evidence
Caveats: Most available evidence is neutral fact or supporting article context, not explicit positive events. Same-day repeated articles around the fundraise are not independent proof beyond corroboration. Some context sources are company-issued or article-level summaries, which are weaker than direct events. |
| 18 | Astrobase Space Technologies mediummedium | Opp 6 Risk 4 | Thesis: Risk remains material because the visible evidence is supporting article context around funding and ambition rather than proof of technical milestone completion, customer adoption, or flight success. Deep-tech engine development inherently depends on execution, but the reviewed sources does not document adverse events. Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters. Evidence
Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence. |
| 19 | Astroscale mediummedium | Opp 7 Risk 4 | Thesis: The reviewed sources also indicates Astroscale is still transitioning from technology demonstrations into repeatable commercial work, and its May 2026 financing cites an uncertain market environment, so scaling and capital-market dependence remain meaningful risks. Why now: Recency is the main reason: on June 22, 2026 SpaceNews said Astroscale was 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' and saw 'repeatable business opportunities' particularly among defense customers. On May 19, 2026 financing materials said the company would raise 30.6 billion yen to secure medium-to-long-term growth funding 'in anticipation of transitioning to a phase of continuous order acquisition'. On April 6, 2026 Astroscale revealed its ISSA-J1 mission scheduled for launch in 2027. Evidence
Caveats: Most within the recent evidence window evidence is supporting article context, not structured company-specific events; reviewed sources warns supporting article context is weaker than direct event/fact evidence. Same-article repeated weak-context rows are not independent confirmation. Older 2023 and 2025 articles exist in representative articles but fall outside the 90-day recent evidence window for ranking use. |
| 20 | BlackSky Technology Inc. highstrong | Opp 8 Risk 4 | Thesis: Risk is still moderate because the $99 million item is an IDIQ ceiling with only initial funding disclosed, and much of the reviewed sources support is article-context level rather than dated events; execution on next-generation payload design and constellation roadmap still matters. Why now: The why-now is supported by two dated recent wins inside the recent evidence window: on March 31, 2026 BlackSky said it received a multi-year sole-source $99 million U.S. government IDIQ and initial $2 million funding for advanced large-aperture payload design; on April 22, 2026 it announced a competitive $25 million multi-year assured contract with a major international defense customer and said it had four Gen-3 satellites on orbit and was rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue. Evidence
Caveats: The $99 million figure is an IDIQ ceiling, not fully funded revenue at announcement; only an initial $2 million was specifically disclosed. Some corroboration repeats the same underlying announcement and should not be treated as independent evidence |